Activin levels correlate with lymphocytic infiltration in epithelial ovarian cancer

Abstract Objective The TGF‐β superfamily member activin, a dimer of the gene products of INHBA and/or INHBB, has been implicated in immune cell maturation and recruitment, but its immune impact within epithelial ovarian cancer (EOC) is not well characterized. We sought to explore differences in acti...

Full description

Saved in:
Bibliographic Details
Main Authors: Elizabeth T. Evans, Emily F. Page, Alex Seok Choi, Zainab Shonibare, Andrea G. Kahn, Rebecca C. Arend, Karthikeyan Mythreye
Format: Article
Language:English
Published: Wiley 2024-09-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.7368
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1825206496873414656
author Elizabeth T. Evans
Emily F. Page
Alex Seok Choi
Zainab Shonibare
Andrea G. Kahn
Rebecca C. Arend
Karthikeyan Mythreye
author_facet Elizabeth T. Evans
Emily F. Page
Alex Seok Choi
Zainab Shonibare
Andrea G. Kahn
Rebecca C. Arend
Karthikeyan Mythreye
author_sort Elizabeth T. Evans
collection DOAJ
description Abstract Objective The TGF‐β superfamily member activin, a dimer of the gene products of INHBA and/or INHBB, has been implicated in immune cell maturation and recruitment, but its immune impact within epithelial ovarian cancer (EOC) is not well characterized. We sought to explore differences in activin (INHBA/ Inhibin‐βA and INHBB/ Inhibin‐βB) between malignant and ovarian tissues at the RNA and protein level and assess the relationship between activin and immune cells in EOC. Methods Publicly available RNA sequencing data were accessed from GEO (#GSE143897) with normalization and quantification performed via DESeq2. Immune gene expression profile was further explored within the TCGA‐OV cohort derived from The Cancer Genome Atlas (TCGA). Immunohistochemical analysis was performed to evaluate activin A and T‐cell markers CD8 and FoxP3 at the protein level. ELISA to activin‐A was used to assess levels in the ascites of advanced EOC patients. Kaplan–Meier curves were generated to visualize survival outcomes. Results Gene expression levels of components of the activin signaling pathway were elevated within EOC when compared to a benign cohort, with differences in activin type I/II receptor gene profiles identified. Additionally, INHBA gene expression was linked to lymphocytic immune markers in EOC samples. Immunohistochemistry analysis revealed a positive correlation of CD8 and FOXP3 staining with activin A at the protein level in both primary and metastatic epithelial ovarian cancer samples. Furthermore, Activin‐A (inhibin‐βA) is significantly elevated in EOC patient ascites. Conclusion INHBA expression is elevated within EOC, correlating with worse survival, with activin protein levels correlating with specific immune infiltration. Our findings suggest that activin‐A may play a role in suppressing anti‐tumor immunity in EOC, highlighting its potential as a therapeutic target.
format Article
id doaj-art-9a6ef7941d9d4424a939ec5da6563127
institution Kabale University
issn 2045-7634
language English
publishDate 2024-09-01
publisher Wiley
record_format Article
series Cancer Medicine
spelling doaj-art-9a6ef7941d9d4424a939ec5da65631272025-02-07T09:08:08ZengWileyCancer Medicine2045-76342024-09-011317n/an/a10.1002/cam4.7368Activin levels correlate with lymphocytic infiltration in epithelial ovarian cancerElizabeth T. Evans0Emily F. Page1Alex Seok Choi2Zainab Shonibare3Andrea G. Kahn4Rebecca C. Arend5Karthikeyan Mythreye6Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Heersink School of Medicine University of Alabama School of Medicine Birmingham Alabama USADepartment of Pathology University of Alabama at Birmingham Heersink School of Medicine Birmingham Alabama USADepartment of Pathology University of Alabama at Birmingham Heersink School of Medicine Birmingham Alabama USADepartment of Pathology University of Alabama at Birmingham Heersink School of Medicine Birmingham Alabama USADepartment of Pathology University of Alabama at Birmingham Heersink School of Medicine Birmingham Alabama USADivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, Heersink School of Medicine University of Alabama School of Medicine Birmingham Alabama USADepartment of Pathology University of Alabama at Birmingham Heersink School of Medicine Birmingham Alabama USAAbstract Objective The TGF‐β superfamily member activin, a dimer of the gene products of INHBA and/or INHBB, has been implicated in immune cell maturation and recruitment, but its immune impact within epithelial ovarian cancer (EOC) is not well characterized. We sought to explore differences in activin (INHBA/ Inhibin‐βA and INHBB/ Inhibin‐βB) between malignant and ovarian tissues at the RNA and protein level and assess the relationship between activin and immune cells in EOC. Methods Publicly available RNA sequencing data were accessed from GEO (#GSE143897) with normalization and quantification performed via DESeq2. Immune gene expression profile was further explored within the TCGA‐OV cohort derived from The Cancer Genome Atlas (TCGA). Immunohistochemical analysis was performed to evaluate activin A and T‐cell markers CD8 and FoxP3 at the protein level. ELISA to activin‐A was used to assess levels in the ascites of advanced EOC patients. Kaplan–Meier curves were generated to visualize survival outcomes. Results Gene expression levels of components of the activin signaling pathway were elevated within EOC when compared to a benign cohort, with differences in activin type I/II receptor gene profiles identified. Additionally, INHBA gene expression was linked to lymphocytic immune markers in EOC samples. Immunohistochemistry analysis revealed a positive correlation of CD8 and FOXP3 staining with activin A at the protein level in both primary and metastatic epithelial ovarian cancer samples. Furthermore, Activin‐A (inhibin‐βA) is significantly elevated in EOC patient ascites. Conclusion INHBA expression is elevated within EOC, correlating with worse survival, with activin protein levels correlating with specific immune infiltration. Our findings suggest that activin‐A may play a role in suppressing anti‐tumor immunity in EOC, highlighting its potential as a therapeutic target.https://doi.org/10.1002/cam4.7368activinmetastasisovarian cancertumor immune infiltration
spellingShingle Elizabeth T. Evans
Emily F. Page
Alex Seok Choi
Zainab Shonibare
Andrea G. Kahn
Rebecca C. Arend
Karthikeyan Mythreye
Activin levels correlate with lymphocytic infiltration in epithelial ovarian cancer
Cancer Medicine
activin
metastasis
ovarian cancer
tumor immune infiltration
title Activin levels correlate with lymphocytic infiltration in epithelial ovarian cancer
title_full Activin levels correlate with lymphocytic infiltration in epithelial ovarian cancer
title_fullStr Activin levels correlate with lymphocytic infiltration in epithelial ovarian cancer
title_full_unstemmed Activin levels correlate with lymphocytic infiltration in epithelial ovarian cancer
title_short Activin levels correlate with lymphocytic infiltration in epithelial ovarian cancer
title_sort activin levels correlate with lymphocytic infiltration in epithelial ovarian cancer
topic activin
metastasis
ovarian cancer
tumor immune infiltration
url https://doi.org/10.1002/cam4.7368
work_keys_str_mv AT elizabethtevans activinlevelscorrelatewithlymphocyticinfiltrationinepithelialovariancancer
AT emilyfpage activinlevelscorrelatewithlymphocyticinfiltrationinepithelialovariancancer
AT alexseokchoi activinlevelscorrelatewithlymphocyticinfiltrationinepithelialovariancancer
AT zainabshonibare activinlevelscorrelatewithlymphocyticinfiltrationinepithelialovariancancer
AT andreagkahn activinlevelscorrelatewithlymphocyticinfiltrationinepithelialovariancancer
AT rebeccacarend activinlevelscorrelatewithlymphocyticinfiltrationinepithelialovariancancer
AT karthikeyanmythreye activinlevelscorrelatewithlymphocyticinfiltrationinepithelialovariancancer